3-179210289-TAGA-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM4_SupportingPP5_Very_Strong
The NM_006218.4(PIK3CA):c.1359_1361delAGA(p.Glu453del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
PIK3CA
NM_006218.4 disruptive_inframe_deletion
NM_006218.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.57
Genes affected
PIK3CA (HGNC:8975): (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The protein encoded by this gene represents the catalytic subunit, which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdIns(4,5)P2. This gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene of this gene has been defined on chromosome 22. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM1
In a domain C2 PI3K-type (size 157) in uniprot entity PK3CA_HUMAN there are 6 pathogenic changes around while only 1 benign (86%) in NM_006218.4
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_006218.4. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant 3-179210289-TAGA-T is Pathogenic according to our data. Variant chr3-179210289-TAGA-T is described in ClinVar as [Pathogenic]. Clinvar id is 39706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIK3CA | NM_006218.4 | c.1359_1361delAGA | p.Glu453del | disruptive_inframe_deletion | 8/21 | ENST00000263967.4 | NP_006209.2 | |
PIK3CA | XM_006713658.5 | c.1359_1361delAGA | p.Glu453del | disruptive_inframe_deletion | 8/21 | XP_006713721.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIK3CA | ENST00000263967.4 | c.1359_1361delAGA | p.Glu453del | disruptive_inframe_deletion | 8/21 | 2 | NM_006218.4 | ENSP00000263967.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Apr 01, 2022 | The PIK3CA c.1359_1361del; p.Glu453del variant (rs587776933) is reported in the literature in several individuals affected with megalencephaly-capillary malformation (MCAP) or megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndromes and was found to occur de novo in at least two (Mirzaa 2016, Riviere 2012). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant deletes a single glutamate residue leaving the rest of the protein in-frame. Functional studies suggest cells expressing the variant protein have increased phosphatidylinositol-3,4,5-triphosphate levels, suggestive of elevated PI3K-AKT-mTOR signaling (Riviere 2012). Additionally, another variant at this codon (c.1357G>A; p.Glu453Lys) has been reported in individuals with MCAP or other overgrowth syndromes and is considered disease-causing (Mirzaa 2016). Based on available information, the p.Glu453del variant is considered to be pathogenic. References: Mirzaa G et al. PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight. 2016 Jun 16;1(9):e87623. PMID: 27631024. Riviere JB et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet. 2012 Jun 24;44(8):934-40. PMID: 22729224. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 14, 2024 | Published functional studies demonstrate a damaging effect. Immunostaining of c.1359_1361delAGA mutant lymphoblastiod cell lines support that this variant impairs protein function, as predicted by in-silico analyses, including protein predictors and evolutionary conservation (PMID: 22729224); Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 1 amino acid(s) in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26226847, 26593112, 27631024, 27191687, 22729224, 33057194, 35982159) - |
Megalencephaly-capillary malformation-polymicrogyria syndrome Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 24, 2012 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Medical Genetics Laboratory, Aldo Moro University of Bari | Jun 06, 2021 | - - |
Cowden syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 20, 2022 | This variant, c.1359_1361del, results in the deletion of 1 amino acid(s) of the PIK3CA protein (p.Glu453del), but otherwise preserves the integrity of the reading frame. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 39706). This variant has been observed in individual(s) with PIK3CA-related overgrowth syndrome (PMID: 22729224, 27631024, 28502725, 32778138; Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at